Instrumental or Physical-Exercise Rehabilitation of Balance in Parkinson's Disease? (IPER-PD)
Trial
N/A
Completed
Oct. 18, 2017
Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease
Trial
Phase 2
Unknown
Oct. 16, 2017
Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease
Trial
N/A
Completed
Oct. 15, 2017
Study in Parkinson's Disease of Exercise
Trial
N/A
Completed
Oct. 12, 2017
Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders
Trial
N/A
Completed
Oct. 11, 2017
Determining Clinical Profile of Parkinson's Disease Among Egyptian Population
Trial
N/A
Unknown
Oct. 9, 2017
Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy Volunteers
Trial
N/A
Completed
Oct. 9, 2017
COPE-Co-morbidities, Parkinson's Disease and Exercise
Trial
N/A
Completed
Oct. 8, 2017
Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease
Trial
Phase 1
Withdrawn
Oct. 5, 2017
The Effect of Lesion Characteristics in MRgFUS on Tremor in Essential Tremor and Parkinson's Disease
Trial
N/A
Completed
Oct. 2, 2017
Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's Disease
Trial
N/A
Completed
Sept. 28, 2017
Pharmacokinetic of Levodopa Study in Healthy Males
Trial
Phase 1
Completed
Sept. 25, 2017
Pilates as an Adjuvant Therapy in Parkinson Disease.
Trial
N/A
Completed
Sept. 25, 2017
Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
Trial
Phase 3
Terminated
Sept. 24, 2017
Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease
Trial
N/A
Completed
Sept. 24, 2017
A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging
Trial
Phase 2
Terminated
Sept. 17, 2017
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Trial
Phase 3
Terminated
Sept. 17, 2017
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
Trial
Phase 4
Completed
Sept. 14, 2017
A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient
Trial
Phase 2
Unknown
Sept. 13, 2017